Immunoe International Research Centers

Thornton, Colorado 80233

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Atopic Dermatitis, Primary Immunodeficiency Diseases (PID)

Studies at this site

• Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global) — Completed
• 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed